Celldex Therapeutics, Inc.

CLDX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$36,037$23,044$17,136$28,356
Short-Term Investments$547,186$607,293$656,155$696,925
Receivables$90$90$1,064$700
Inventory$0$0$0$0
Other Curr. Assets$21,026$17,977$19,402$21,178
Total Curr. Assets$604,339$648,404$693,757$747,159
Property Plant & Equip (Net)$7,546$7,513$8,115$8,244
Goodwill$0$0$0$0
Intangibles$27,190$27,190$27,190$27,190
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$9,364$9,300$10,409$9,747
Total NC Assets$44,100$44,003$45,714$45,181
Other Assets$0$0$0$0
Total Assets$648,439$692,407$739,471$792,340
Liabilities
Payables$4,267$2,073$3,410$3,265
Short-Term Debt$1,553$1,536$1,499$1,452
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$40,645$29,354$27,109$34,784
Total Curr. Liab.$46,465$32,963$32,018$39,501
LT Debt$1,068$1,495$1,929$2,361
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,543$2,543$2,543$3,473
Total NC Liab.$3,611$4,038$4,472$5,834
Other Liabilities$0$0$0$0
Cap. Leases$2,621$3,031$3,428$3,813
Total Liabilities$50,076$37,001$36,490$45,335
Equity
Pref Stock$0$0$0$0
Common Stock$66$66$66$66
Retained Earnings-$1,732,664-$1,665,620-$1,609,020-$1,555,224
AOCI$3,765$3,339$3,568$3,314
Other Equity$2,327,196$2,317,621$2,308,367$2,298,849
Total Equity$598,363$655,406$702,981$747,005
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$648,439$692,407$739,471$792,340
Net Debt-$33,416-$20,013-$13,708-$24,543